胚胎干细胞、成体干细胞、肿瘤干细胞、间充质干细胞与 iPSCs（含 iPSC 衍生细胞），配套专用培养基与诱导方案。 共 669 个产品。
Human iPSC From Fibroblast-Isogenic Control, Vici Syndrome provides a model for gene therapy and Vici syndrome research in cellular and genetic studies.
Human iPSC From Fibroblast-Leigh Syndrome provides a disease-relevant iPSC model for mitochondrial dysfunction, energy metabolism, and drug discovery.
Human iPSC From Fibroblast-Long QT Syndrome 3 ,iPSCs derived from LQT3 fibroblasts for cardiac arrhythmia, ion channel dysfunction, and disease modeling.
Human iPSC From Fibroblast-Maturity Onset Diabetes ,Fibroblast-derived iPSCs for maturity onset diabetes research, disease modeling, and therapy studies.
Human iPSC From Fibroblast-Mental Retardation ,iPSC model for autosomal dominant MRD40 studies, CHAMP1 biology, neurodevelopment, and disease mechanisms.
The Human iPSC From Fibroblast-Miller-Dieker Lissencephaly Syndrome provides a model for neuronal studies, genetic analysis, and drug research.
Assess Human iPSC From Fibroblast-Mucopolysaccharidosis Type II, high-quality iPSC line for studying IDS function and MPS II disease modeling.
Human iPSC From Fibroblast-Mucopolysaccharidosis Type IVA offers a disease-specific iPSC model for MPS IVA-related developmental and drug research.
Human iPSC From Fibroblast-Dystroglycanopathy Type B enables disease modeling, drug screening, and therapeutic research in muscular dystrophy.
Human iPSC From Fibroblast-Muscular Dystrophy, Becker Type delivers disease-relevant iPSCs for muscular dystrophy modeling and drug discovery.
Human iPSC From Fibroblast-Neuroaxonal Dystrophy provides a disease-specific model for neurodegeneration, axonal pathology, and therapeutic screening.
Human iPSC From Fibroblast-Neurodegeneration With Brain Iron Accumulation 5 provides a patient-derived stem cell model for neurodegenerative research.
Human iPSC From Fibroblast-Neuropathy, Hereditary Sensory And Autonomic,Type III,High-quality iPSC line for studying HSAN3, IKBKAP function, neuronal diff.
Explore Human iPSC From Fibroblast-Niemann-Pick Disease Type B for disease modeling, SMPD1 deficiency studies, and therapeutic drug evaluation.
Human iPSC From Fibroblast-Osteogenesis Imperfecta, Type IV is a model for studying genetic disorders and therapeutic approaches in bone biology.
Human iPSC From Fibroblast-Rett Syndrome offers patient-derived pluripotent cells for Rett syndrome disease modeling and therapeutic development.
Human iPSC From Fibroblast-Rett Syndrome, Congenital Variant serves as a model for neurodevelopmental disease research and drug screening studies.
The Human iPSC From Fibroblast-Rett Syndrome, Congenital Variant models MECP2-related neurological disorders for the therapeutic development.
Human iPSC From Fibroblast-Scheie Syndrome offers disease-specific iPSCs to study lysosomal storage disorders, pathogenesis, and therapeutic approaches.
The Human iPSC from Fibroblast-Schuurs-Hoeijmakers Syndrome provides a model for studying the genetic and cellular basis of this rare syndrome.
Human iPSC From Fibroblast-Severe Combined Immunodeficiency offers a pluripotent model for immunodeficiency research and regenerative studies.
Human iPSC From Fibroblast-Tay-Sachs Disease offers a model to investigate GM2 gangliosidosis pathology and therapeutic approaches in vitro.
Human iPSC From Fibroblast-Trisomy 21: High-quality cell line ideal for studies on Trisomy 21.
Human iPSC From Fibroblast-Tuberous Sclerosis 1 offers a disease-relevant pluripotent stem cell model for TSC1 deficiency and drug discovery.
共 669 个产品 ｜ 第 27 / 28 页
